Metraipolis › archive › dc_cf7004faf710

Adenosine deaminase 2 deficiency — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Adenosine_deaminase_2_deficiency
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-07T14:10:34.592Z
SHA-256 of the archived text
a28a67405af846c0fe820d90de8db54381f0fd51574c96f79b408271ebc0436e
Stable URL of this page
https://metraipolis.com/documento/dc_cf7004faf710

How to cite

Adenosine deaminase 2 deficiency — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Adenosine_deaminase_2_deficiency (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_cf7004faf710 (Metraipolis archive dc_cf7004faf710, sha256 a28a67405af846c0fe820d90de8db54381f0fd51574c96f79b408271ebc0436e)
BibTeX
@misc{dccf7004faf710,
  title = {Adenosine deaminase 2 deficiency — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Adenosine_deaminase_2_deficiency},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_cf7004faf710; sha256 a28a67405af846c0fe820d90de8db54381f0fd51574c96f79b408271ebc0436e},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Adenosine_deaminase_2_deficiency. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Deficiency of Adenosine deaminase 2 (DADA2) is a monogenic disease associated with systemic inflammation and vasculopathy that affects a wide variety of organs in different patients. As a result, it is hard to characterize a patient with this disorder. Manifestations of the disease include but are not limited to recurrent fever, livedoid rash (reticularis or racemosa), various cytopenias, stroke, immunodeficiency, and bone marrow failure. Symptoms often onset during early childhood, but some cases have been discovered as late as 65 years old. DADA2 is caused by mutations in the ADA2 gene, and is inherited in an autosomal recessive manner. The protein product of this gene, adenosine deaminase 2 (ADA2), is an extracellular enzyme that breaks down adenosine and may also serve as a growth factor. Pathogenic mutations decrease this enzymatic activity in patient blood, leading to disease manifestations. However, mutational status and residual enzyme activity levels do not explicitly correlate with the type of disease a patient displays. The most common treatment for DADA2 is TNF inhibitors. This therapy tends to prevent vasculitis-related manifestations such as rash and stroke, but does not perform well in individuals presenting with severe hematologic and immunologic abnormalities such as bone marrow failure or severe recurrent infections. In these cases, hematopoietic stem cell transplantation has led to major improvements in the vascular, hematologic, and immunologic manifestations of disease.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Adenosine deaminase 2 deficiency» — https://en.wikipedia.org/wiki/Adenosine_deaminase_2_deficiency
Wikidata Q55603216: «human genetic disorder» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q55603216
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Adenosine_deaminase_2_deficiency?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1334895539, consultata il 2026-11-07T14:06:21.604Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 909f67c0ce02d1ff70e54236ee02a77a4fdb6f0b5553fac3141d757000386123